BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $344,000 | +14.3% | 2,902 | -6.5% | 0.02% | +46.2% |
| Q2 2021 | $301,000 | -21.2% | 3,104 | -30.3% | 0.01% | -59.4% |
| Q4 2020 | $382,000 | -33.2% | 4,455 | -49.4% | 0.03% | -48.4% |
| Q3 2020 | $572,000 | +123.4% | 8,800 | +151.4% | 0.06% | +44.2% |
| Q2 2020 | $256,000 | – | 3,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |